Trial Site Detail
Drug: |
PF-052112384 + PD-0325901 OR PF-052112384 + Irinotecan |
|||
|---|---|---|---|---|
Trial: |
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Terminated |
|||
Premier Oncology, Santa Monica2020 Santa Monica Boulevard Suite 600 Suite 600 |
Principal Investigator: |
|
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Premier Oncology, Santa Monica Website: |
http://www.premiereoncology.com/po/index.php?option=com_content&task=category§ionid=4&id=70&Itemid=55 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.